Low prevalence of IgG antibodies to SARS-CoV-2 in cancer patients with COVID-19

TY - JOUR

T1 - Low prevalence of IgG antibodies to SARS-CoV-2 in cancer patients with COVID-19

AU - COVID-19 in Cancer Patients Research Group

AU - Liu, Tao

AU - Zeng, Guang

AU - Tao, Huangheng

AU - Shi, Yue

AU - Wang, Ting

AU - Liu, Tongzu

AU - Guo, Fangjian

AU - Zhou, Fuling

AU - Wang, Xinghuan

N1 - Funding Information: Part of the study was supported by the National Key Research and Development Program of China (2020YFC0845500, principal investigator: Dr X. W.). Dr F. G. is supported by the National Cancer Institute of National Institute of Health under Award Number K07CA222343. The content is solely the responsibility of the authors and does not necessarily represent the official views of the sponsors. The sponsors had no role in the design and conduct of the study; collection, management, analysis and interpretation of the data; and preparation, review or approval of the manuscript and decision to submit the manuscript for publication.

PY - 2020/12/1

Y1 - 2020/12/1

UR - http://www.scopus.com/inward/record.url?scp=85087147561&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85087147561&partnerID=8YFLogxK

U2 - 10.1002/ijc.33148

DO - 10.1002/ijc.33148

M3 - Letter

C2 - 32525566

AN - SCOPUS:85087147561

SN - 0020-7136

VL - 147

SP - 3267

EP - 3269

JO - International Journal of Cancer

JF - International Journal of Cancer

IS - 11

ER -